We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current NVYTF market cap is 41.25M. The company's latest EPS is GBP and P/E is N/A.
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Revenue | 12.64M | 277.2M | 95.78M | 22.49M | 11.58M |
Operating Income | -3.59M | 167.52M | -7.79M | -33.21M | -30.34M |
Net Income | -5.75M | 132.42M | -9.73M | -25.73M | -28.29M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Assets | 26.53M | 234.28M | 183.7M | 140.9M | 133.82M |
Total Liabilities | 14.07M | 83.57M | 41.88M | 25.69M | 46.57M |
Total Equity | 12.46M | 150.71M | 141.82M | 115.22M | 87.24M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Operating | -940k | 102.98M | 15.69M | -13.73M | -24.99M |
Investing | -1.05M | -7.97M | -5.03M | -577k | -13.94M |
Financing | 2.5M | -5.04M | -599k | -516k | -3.97M |
Market Cap | 41.25M |
Price to Earnings Ratio | N/A |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 70.63M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 273 |
52 Week Change | -21.58% |
52 Week High | 1.25 |
52 Week Low | 0.50 |
Spread (Intraday) | 0.04 (5.89%) |
Company Name | Novacyt Clamart (PK) |
Address |
13 avenue morane saulnier velizy-villacoublay, yvelines 78140 |
Website | https://www.novacyt.com |
Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions